20.2 Palliative Care, Opioid Conversions, and Oncological Emergencies

Key Takeaways

  • Match cancer pain treatment to severity, route, kidney function and the person’s goals. Start a bowel regimen with regular opioids and review nausea and other adverse effects.

  • Use a named conversion chart and separate the 24-hour background and rescue doses. A route switch, opioid rotation and fentanyl patch each require a specific plan.

  • Morphine metabolites can accumulate in renal impairment. Reassess and monitor for toxicity, and obtain specialist advice on safer alternatives. Treat clinically important hypoventilation with ventilation support and appropriately titrated naloxone.

  • In adults and children, agree individual indications, doses, routes and review of anticipatory medicines. Before paediatric discharge, confirm supplies, who can give treatment and the escalation plan.

  • Escalate suspected cord compression and neutropenic sepsis urgently. Tailor treatment of hypercalcaemia, SVC obstruction and catastrophic bleeding to the findings and agreed goals of care.

Last updated: November 2026

Assess symptoms and agree the goals of care

Palliative care addresses physical, psychological, social and spiritual needs in serious illness. It can run alongside disease-directed treatment. Ask what is most troubling, what matters to the person now and whom they want involved. Clarify the likely benefits and burdens of interventions and agree when to contact the care team or transfer to hospital. Share the plan with the relevant teams, particularly before discharge home. HSE adult palliative care implementation plan · HSE rapid discharge pathway

Total pain and treatment selection

DomainClinical exampleResponse
PhysicalBone pain on weight-bearing, neuropathic shooting pain, pressure injury or constipationExamine and treat the cause where possible, choose analgesia and reassess function
PsychologicalFear of dying, anxiety, depression or loss of autonomyListen, assess distress and offer psychological and clinical support
SocialFinancial strain, isolation or exhaustion of a carerAssess practical help and involve the multidisciplinary team
Spiritual or existentialLoss of meaning or worries about unfinished relationshipsAsk how the person wants to be supported and offer appropriate spiritual care

The traditional WHO ladder distinguishes non-opioids, weaker opioids and strong opioids. Choose treatment at the level appropriate to the current pain and clinical context. Moderate to severe cancer pain can justify a strong opioid without requiring a trial of a weaker one. Use the oral route when practical, with a schedule for persistent pain and access to rescue analgesia. Immediate-release or modified-release oral opioids can be used to start titration in appropriate patients. Morphine is a common reference drug. Review renal function, frailty, previous opioid exposure and ability to swallow before choosing a drug, formulation and starting dose. Reassess analgesia, function, sedation and adverse effects. WHO cancer pain guideline · Irish NCEC cancer pain guideline

  • Non-opioids and adjuvants. Adjust paracetamol for low body weight and hepatotoxicity risk under the HSE prescribing advice. Consider an NSAID for suitable patients, with review of gastrointestinal, renal and cardiovascular risk. Codeine depends on CYP2D6 for conversion to morphine. Tramadol can increase seizure and serotonergic risk. HPRA codeine · HPRA tramadol A neuropathic pain agent may help with burning pain or allodynia. Renally adjust gabapentinoids and consider additive sedation with an opioid. Localised painful bone metastases may respond to palliative radiotherapy. Use steroids or bone-targeted medicines for an indication agreed with the specialist team. HSE paracetamol safety guidance
  • Bowel care and nausea. Start an appropriate bowel regimen with regular opioids. The Irish palliative constipation guideline advises optimising a stimulant for opioid-induced constipation and adding a softener if required. Avoid stimulants in partial intestinal obstruction and laxatives in complete obstruction. Check for constipation and other causes of nausea, and offer a cause-directed antiemetic when indicated. A prokinetic may help gastric stasis in selected patients and is inappropriate in complete mechanical obstruction. Irish NCEC palliative constipation guideline

Adult consent and anticipatory planning in Ireland

Support the person's ability to make each decision and record their current wishes. A valid and applicable advance healthcare directive can refuse a specific treatment if the person lacks capacity for that decision. A refusal of life-sustaining treatment must expressly apply even if life is at risk. Check the authority of a designated healthcare representative where one was appointed. Family can help communicate the person's wishes and may have a formal role if legally authorised. A DNAR decision concerns CPR. Other appropriate treatment and comfort measures still depend on their individual indications and the person's wishes. Make specific plans for predictable crises, including whom to contact and any anticipatory medicines. HSE National Consent Policy · Revised Capacity Act section 85 · Decision Support Service advance directives

Distinguish pronouncement, certification and reporting

After a death, support those close to the person and document the circumstances. Pronouncement means confirming and recording the fact that life has ceased. Follow the local procedure. The HSE policy permits a trained registered nurse to pronounce death in specified services and circumstances. Medical certification of the cause is a separate responsibility of an eligible registered medical practitioner. Report a death falling within a statutory category or where the cause cannot lawfully be certified to the Coroner. A death that was anticipated can still require reporting because of its circumstances or local rules. If the circumstances differ from the expected plan or are uncertain, consult the senior clinician and follow the local reporting pathway.

HSE pronouncement policy · Irish Coroners Act reportable deaths · Department of Justice reporting guidance

Convert adult opioids by drug, route and 24-hour dose

Record the drug, formulation, route, scheduled 24-hour dose, recent rescue use and time of the last administration. Check renal function, frailty, pain control and toxicity. The equivalence is an estimate. When switching to a different opioid, consider incomplete cross-tolerance, the reason for rotation and drug-specific exceptions. The Our Lady's Hospice chart notes a 30–50% reduction to consider when applicable. Its tabulated doses have no reduction built in. Agree the starting and rescue doses, timing and monitoring with the specialist team. Irish NCEC conversion tables · Our Lady's Hospice opioid chart

ConversionReference example before clinical adjustment
Oral morphine to SC morphine, 2:160 mg/24 h÷2=30 mg SC/24 h60\text{ mg}/24\text{ h} \div 2 = 30\text{ mg SC}/24\text{ h}
Oral morphine to oral oxycodone, 1.5:1 or 2:1 depending on chart60 mg/24 h60\text{ mg}/24\text{ h} oral morphine corresponds to about 3030–40 mg/24 h40\text{ mg}/24\text{ h} oral oxycodone
Oral to SC oxycodone, 2:1 on the hospice chart30 mg/24 h÷2=15 mg SC/24 h30\text{ mg}/24\text{ h} \div 2 = 15\text{ mg SC}/24\text{ h}
Oral morphine to SC alfentanil, about 30:1 on the hospice chart or 32:1 in NCECHospice chart example 60 mg/24 h÷30=2 mg SC alfentanil/24 h60\text{ mg}/24\text{ h} \div 30 = 2\text{ mg SC alfentanil}/24\text{ h}

Rescue doses and worked changes

For immediate-release morphine, one sixth of the regular 24-hour dose is a commonly used starting calculation. One tenth is a lower starting estimate discussed in the Irish guideline evidence review. The guideline recommends individual titration. Use the correct route equivalent and prescribe an interval and review plan. Frequent rescue use calls for reassessment of the pain pattern, benefit and adverse effects before a background dose change. Individually titrate rapid-onset fentanyl products for their approved indications. The one-sixth calculation does not set their dose.

  • Retitration. Modified-release oral morphine 30 mg30\text{ mg} twice daily gives 60 mg/24 h60\text{ mg}/24\text{ h}. A one-sixth oral rescue dose is 10 mg10\text{ mg}. Three effective rescues add 30 mg30\text{ mg}, for 90 mg90\text{ mg} taken in 24 hours. If reassessment supports incorporating that rescue use into baseline analgesia, 45 mg45\text{ mg} twice daily supplies 90 mg/24 h90\text{ mg}/24\text{ h} and the same one-sixth calculation yields 15 mg15\text{ mg} orally. Check the available formulation and review after the change. Incident pain, new sedation or impaired renal function can change this decision.
  • Patch conversion. In the Irish Durogesic DTrans product information, 60 mg60\text{ mg} oral morphine per day falls in the 4545–89 mg89\text{ mg} band for a 25 micrograms/h25\text{ micrograms/h} patch in stable, well-tolerated opioid therapy. It falls in the band for 12 micrograms/h12\text{ micrograms/h} in the more conservative conversion table for rotation or less stable patients. A patch delivers a rate. For example, 25 micrograms/h×24 h=600 micrograms25\text{ micrograms/h} \times 24\text{ h} = 600\text{ micrograms} of fentanyl in 24 hours. It is generally for opioid-tolerant patients and is unsuitable for rapidly changing acute pain. Plan overlap according to the previous formulation and route. The depot persists after removal. External heat and fever can increase exposure. HPRA Durogesic DTrans product information · Our Lady's Hospice route changes

Kidney function and opioid rotation

Morphine glucuronides accumulate when renal clearance declines. Morphine-6-glucuronide contributes to prolonged opioid effect and can depress breathing. Sedation, hallucinations and myoclonus can suggest toxicity, especially after starting or increasing morphine in a patient with renal impairment. Generally avoid morphine or codeine in severe impairment when suitable alternatives exist. The Irish NCEC guideline identifies alfentanil and fentanyl as options in stage 4–5 CKD, with specialist prescribing and close review. The formulation still matters. A transdermal fentanyl patch is unsuitable for rapid titration. Oxycodone also requires caution. Choose and prescribe rescue medication separately if using alfentanil by infusion. Its short duration and available formulations affect that decision. Irish NCEC renal recommendations · Our Lady's Hospice alfentanil guidance

A theoretical switch from 90 mg/24 h90\text{ mg}/24\text{ h} oral morphine to SC alfentanil using a 30:1 chart gives 3 mg/24 h3\text{ mg}/24\text{ h}. One third less would give 2 mg/24 h2\text{ mg}/24\text{ h}. In a patient with suspected toxicity, this illustrates the calculation only. Hold or reduce the offending drug as appropriate, assess the patient and agree the timing and dose with the specialist team before starting a new opioid.

Relieve distress and recognise emergencies

Opioid toxicity and ventilatory support

Assess airway, ventilation, alertness and recent dosing. New drowsiness, confusion, hallucinations or myoclonus warrant review for opioid toxicity and contributing problems such as acute kidney injury, dehydration, infection and other sedatives. With preserved ventilation, hold the next dose if clinically appropriate, address reversible causes and obtain advice on a safer dose or opioid. Reassess closely because ventilation can deteriorate. Give fluids for clinically significant dehydration when appropriate to the person's condition and goals.

When there is clinically important opioid-induced hypoventilation, call for help, support ventilation and titrate naloxone to adequate breathing. In a monitored therapeutic-opioid setting with risk of withdrawal, follow the local low-dose regimen if suitable. Galway adult IV guidance uses an initial 100–200 micrograms in its low-dose regimen, with further titration to response. A preparation of 400 micrograms in a final volume of 10 mL gives 40 micrograms/mL, so 100 micrograms is 2.5 mL. Severe poisoning or near-apnoea requires immediate resuscitation and a regimen that restores ventilation promptly. Continue monitoring because toxicity can recur after naloxone wears off. Repeat doses or an infusion may be needed. Galway adult IV naloxone guidance

Symptoms in the last days of life

Prescribe anticipatory medicines for the symptoms the person is likely to experience. Specify indication, dose, route, interval and when to seek review. Check reversibility, expected benefit and the person's wishes before administering them. When oral treatment becomes impractical and ongoing doses are required, consider a continuous subcutaneous infusion (CSCI) for maintenance. Keep an appropriate PRN rescue plan. Check drug, concentration, diluent, device, site, compatibility and infusion rate with local policy or pharmacy. Cyclizine is incompatible with sodium chloride in the hospice compatibility guide. Dexamethasone at therapeutic doses generally requires separate administration. HSE care during dying · NICE last days of life · Our Lady's Hospice syringe pump guide

SymptomPractical approach
Pain or breathlessnessMatch an opioid to prior exposure, symptom, route and renal function. Assess reversible causes of breathlessness. In advanced cancer, airflow from a fan, positioning and oxygen for hypoxaemia may help. Consider systemic opioids for persistent distress, and consider a short-acting benzodiazepine for associated anxiety when initial measures are insufficient
Agitation or deliriumReview retention, impaction, pain, medication effects and other treatable contributors as appropriate. Use a calm environment. Consider specialist-directed medication for distressing agitation, such as midazolam in the dying phase. Avoid automatic treatment with an antipsychotic for all delirium
Nausea or vomitingChoose an antiemetic by likely mechanism and adverse effects. In malignant bowel obstruction, assess whether an intervention or decompression may help. Metoclopramide may be considered in partial obstruction. Avoid it in complete obstruction. Octreotide can reduce vomiting. Specialist teams may use an antisecretory drug or a short steroid trial
Noisy secretionsExplain that the sound is often more distressing to relatives than the patient. Reposition if helpful. Consider a trial of an antisecretory medicine such as glycopyrronium or hyoscine butylbromide if secretions are causing distress, and review benefit and adverse effects

The evidence for routine opioids in chronic non-malignant respiratory disease differs from advanced cancer and care in the last days of life. ASCO advanced cancer dyspnoea · ERS serious respiratory illness · MASCC malignant bowel obstruction

Relieve symptoms and plan community care for a child

Involve the child in a way they can understand and ask what they and their family hope to achieve. Ask carers about usual behaviour and signs of pain or distress, particularly when the child cannot describe symptoms. Reassess for treatable causes such as urinary retention, constipation or uncomfortable positioning. Use positioning, familiar carers and other comfort measures as appropriate, and review the response to treatment. The paediatric and palliative teams choose medicines and doses using the child's age, weight, prior exposure, organ function and the least distressing feasible route. Check regular and rescue instructions and adverse effects. Adult opioid conversion examples apply only to the adult scenarios here.

When a child with a life-limiting condition and their family wish to receive end-of-life care at home, use the HSE integrated discharge pathway. Involve the primary paediatric team, community teams and paediatric palliative expertise as needed. Agree who will be responsible, what to do if symptoms worsen, who will help out of hours and when to use emergency services. Review needs such as pain relief, breathlessness or seizures, and agree the route if swallowing becomes difficult. Confirm prescriptions, pharmacy supply, equipment and who can administer each treatment. Share the written plan and any applicable emergency or ambulance documents with those who need them. Revisit preferences or practical arrangements as the child's condition changes.

HSE integrated paediatric discharge guidance · Children's Health Ireland specialist paediatric palliative care · NICE NG61 child and young person symptom management

Recognise urgent complications and act on the agreed goals

Metastatic spinal cord compression (MSCC). In a patient with cancer, progressive back pain with new weakness, gait change, sensory signs or bladder or bowel dysfunction needs immediate oncology and spinal escalation. Arrange whole-spine MRI as soon as possible and within 24 hours. With neurological symptoms or signs, give dexamethasone 16 mg orally or an equivalent parenteral dose promptly, with glucose monitoring and PPI protection, then continue 16 mg daily while awaiting surgery or radiotherapy. Immobilise promptly when there are neurological symptoms or signs suggesting spinal instability, and consider it for moderate to severe movement-related pain. Adapt positioning to tolerance and specialist advice. Urgent definitive treatment depends on stability, prognosis and treatment goals. The Irish NCCP interim endorsement applies to NICE NG234 radiotherapy recommendations in section 1.10. The recognition, MRI and steroid recommendations here are from NICE NG234 itself. NICE NG234 · NCCP interim radiotherapy recommendations

Malignant hypercalcaemia. PTH-related peptide, osteolysis and excess calcitriol are possible mechanisms. Confusion, constipation, polyuria, dehydration or a short QT can be clues. Use the laboratory reference range. Albumin-adjusted total calcium is an estimate. Measure ionised calcium when protein binding or pH makes total or adjusted calcium unreliable. Start isotonic saline for volume depletion, reassessing circulation, urine output and cardiac and renal tolerance. Arrange antiresorptive treatment early with the specialist team. Zoledronic acid is EU-authorised for tumour-induced hypercalcaemia. Check its indication-specific renal precautions. For severe disease above 3.5 mmol/L, the Endocrine Society suggests adding short-course calcitonin if available. The same guideline supports denosumab in certain circumstances, but tumour-induced hypercalcaemia is outside Xgeva's EU-authorised indications and requires specialist consideration. Calcium measurement study · Endocrine Society guideline · EMA Zometa · EMA Xgeva

Superior vena cava obstruction. Facial, neck or arm swelling, prominent chest wall veins and breathlessness suggest obstruction from tumour or thrombosis. Elevate the head as tolerated and obtain urgent senior and oncology input. Stridor, respiratory compromise or altered consciousness needs immediate emergency assessment. Contrast CT can define the obstruction and cause. Discuss stenting, tissue diagnosis and cause-directed treatment with the relevant teams. Steroids are selective. Discuss tissue sampling first if lymphoma is suspected and immediate treatment can safely wait. Scottish palliative emergencies guidance · NHS Greater Glasgow and Clyde SVCO guidance

Suspected neutropenic sepsis. Fever or clinical infection after myelosuppressive cancer treatment warrants immediate assessment. Afebrile sepsis is possible. The Galway acute oncology algorithm uses at least 38.3°C once or at least 38°C sustained for one hour, or clinical signs of sepsis. The HSE acute adult sepsis form uses risk of neutropenia from recent treatment as a red flag when assessing infection. Take cultures and blood tests promptly and give empiric IV antibiotics within one hour without waiting for the neutrophil count. Choose the regimen according to local guidance, allergy phenotype, renal function and prior resistant organisms. The Galway algorithm specifies different regimens for no allergy, a non-severe delayed reaction and an immediate or severe delayed reaction. HSE adult acute hospital sepsis form · Galway initial neutropenic sepsis algorithm

Tumour lysis syndrome. Rapid cell breakdown, often after treatment and sometimes spontaneous, can cause hyperkalaemia, hyperphosphataemia, hypocalcaemia, hyperuricaemia and acute kidney injury. Obtain urgent haematology input, monitor and treat metabolic complications, and use risk-based IV hydration and urate-lowering therapy. Allopurinol prevents new uric acid formation. Rasburicase breaks down existing uric acid and is contraindicated in G6PD deficiency. The BSH guideline stops allopurinol when rasburicase starts. BSH 2025 tumour lysis guideline · EMA rasburicase product information

Catastrophic haemorrhage. If a major bleed is foreseeable, agree an emergency plan and accessible contacts with the person, family and team. During a bleed, call for help and follow the agreed escalation and treatment plan. Stay with the person, reassure, position for comfort and use dark towels if available. Apply pressure to an accessible source when appropriate. If distress persists and a rapid-acting sedative is already prescribed and immediately available, a trained clinician may give it under the plan. Maintain bedside support. Offer family and staff follow-up after the event. Scottish palliative emergencies guidance

Loading diagram...
Oncological and Palliative Emergencies Decision Triage
Test Your Knowledge

A 68-year-old man with metastatic prostate cancer takes modified-release oral morphine 60 mg twice daily for stable pain. He has no opioid toxicity or new renal impairment, but can no longer swallow reliably. His palliative team plans to continue morphine by 24-hour continuous subcutaneous infusion (CSCI). Using the hospice 2:1 oral-to-SC conversion and a one-sixth SC rescue dose, what are the calculated doses?

A

120 mg SC morphine over 24 hours, with 20 mg SC morphine PRN

B

40 mg SC morphine over 24 hours, with 10 mg SC morphine PRN

C

60 mg SC morphine over 24 hours, with 10 mg SC morphine PRN

D

30 mg SC morphine over 24 hours, with 5 mg SC morphine PRN

Test Your Knowledge

A 74-year-old woman with advanced colorectal cancer and chronic kidney disease (eGFR 21 mL/min/1.73 m2) was started on oral morphine for worsening abdominal pain 4 days ago. Her daughter brings her to the hospice unit because she has become increasingly drowsy, is seeing insects on the wall, and has developed sudden twitching jerks in both arms. Her pupils are pinpoint and her respiratory rate is 14/min with SpO2 96% on room air. What is the underlying pharmacological cause and best immediate management?

A

Suspect accumulation of renally cleared morphine glucuronides. Hold morphine, reassess and monitor ventilation, treat reversible causes and seek specialist advice on an alternative opioid.

B

Opioid underdosing causing pain-induced delirium; double the oral morphine dose immediately

C

Severe respiratory arrest requiring immediate IV naloxone 800 mcg bolus injection

D

Codeine conversion failure; switch immediately from oral morphine to regular codeine phosphate 60 mg QDS

Test Your Knowledge

A 63-year-old woman with known breast cancer bone metastases presents to the Emergency Department with a 10-day history of progressive mid-thoracic back pain that worsens when lying flat at night, followed today by a tight band-like tingling around her lower ribcage, bilateral leg heaviness requiring a walking frame, and inability to pass urine since morning. On examination, power is 3/5 in hip flexion bilaterally with brisk knee reflexes and upgoing plantar responses. What is the immediate priority management?

A

Perform urinary catheterisation, prescribe oral naproxen, and book an outpatient MRI spine within 2 weeks

B

Administer IV zoledronic acid 4 mg immediately and arrange a plain thoracic spine X-ray

C

Wait for a formal neurosurgical outpatient review before starting any corticosteroids

D

Escalate immediately to the oncology and spinal teams, give dexamethasone 16 mg orally or equivalent parenterally, and arrange whole-spine MRI as soon as possible and within 24 hours.

Test Your Knowledge

A 54-year-old man presents to a Galway emergency department nine days after adjuvant chemotherapy for colon cancer. He has rigors, a single temperature of 38.3°C, pulse 112/min and BP 102/64 mmHg. The team suspects neutropenic sepsis. Blood cultures, full blood count and lactate have been sent and the laboratory results will take 45 minutes. What is the immediate treatment priority?

A

Wait 45 minutes for the absolute neutrophil count result before prescribing antibiotics to preserve antimicrobial stewardship

B

Give empiric broad-spectrum IV antibiotics under the local neutropenic sepsis algorithm within one hour, without waiting for the neutrophil result.

C

Prescribe oral co-amoxiclav and discharge home with a thermometer if chest X-ray is clear

D

Administer subcutaneous filgrastim (G-CSF) monotherapy and observe overnight without antibiotics

Test Your Knowledge

A school-aged child with a life-limiting neurological condition and intermittent seizures is nearing discharge for end-of-life care at home, in line with the family’s wishes. Swallowing is becoming unreliable. What should the clinical team arrange before discharge?

A

Send the existing oral medicines and ask the family to obtain advice if swallowing worsens

B

Use the adult hospice opioid conversion to calculate a standard rescue prescription

C

Agree a paediatric symptom and escalation plan with the child and family, confirm feasible medicine routes and supplies, and give the receiving teams and family written contacts and instructions

D

Delay discussion of seizure or breathing symptoms until after the child has returned home

Sections you finish are checked off in the contents.